Monitoring of Apixaban in a Super Obese Patient

Am J Med. 2019 Jan;132(1):e15-e16. doi: 10.1016/j.amjmed.2018.08.021. Epub 2018 Sep 7.

Authors

Cornelia Fietz¹, Guido Michels², Carsten Müller³, Martin H J Wiesen³

Affiliations

¹ Center of Pharmacology, Therapeutic Drug Monitoring Unit, University Hospital of Cologne/Cologne, Germany. Electronic address: cornelia.fietz@uk-koeln.de.
² Department III of Internal Medicine, Heart Center/University Hospital of Cologne/ Cologne, Germany.
³ Center of Pharmacology, Therapeutic Drug Monitoring Unit, University Hospital of Cologne/Cologne, Germany.

PMID: 30201245
DOI: 10.1016/j.amjmed.2018.08.021

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Factor Xa Inhibitors / pharmacokinetics*
Humans
Male
Middle Aged
Obesity, Morbid*
Pyrazoles / pharmacokinetics*
Pyridones / pharmacokinetics*

Substances

Factor Xa Inhibitors
Pyrazoles
Pyridones
apixaban